Yang, Stephanie J.
Lin, Andrew A.
Shen, Hanfei
Pappalardo, Laura W.
Spychalski, Griffin B.
Rosario, Jean
Forsberg, Leah K.
Grant, Kiera M.
Buser, Joshua R.
Savica, Rodolfo
O’Bryant, Sid
Jones, David T.
Dickson, Dennis W.
Reichard, R. Ross
Nguyen, Aivi T.
Meaney, David F.
Boeve, Bradley F.
Ross, Owen A.
McLean, Pamela J.
Issadore, David
Funding for this research was provided by:
National Institutes of Health (U19 AG063911)
National Institutes of Health (P30 AG062677)
National Institutes of Health (P30 AG062677)
National Institutes of Health (P30 AG062677)
National Institutes of Health (P30 AG062677)
National Institutes of Health (P30 AG062677)
National Institutes of Health (U54 NS110435)
National Institutes of Health (P30 AG062677)
Ted Turner and Family Foundation
American Academy of Neurology/American Brain Foundation Cure One Cure Many Award
Harry T. Mangurian, Jr. Foundation
Little Family Foundation
Article History
Received: 25 September 2025
Accepted: 19 February 2026
First Online: 12 March 2026
Competing interests
: D.I. is a founder and holds shares in Chip Diagnostics. J.R.B. holds ownership of Consonant Systems, LLC, which was paid to produce the mTENPO chips used in this study. The other authors do not have a competing interest. The mTENPO platform is protected under US patent US20240238802A1.